VM

Vivek Menon

Co-founder, Strategy & Finance at Spren

Vivek Menon has a diverse work experience spanning multiple industries. Vivek is currently working at Spren (formerly Elite HRV) in a product and operations role since 2017. Prior to this, they held various positions at NxStage Medical, Inc. From 2015 to 2016, they served as the Vice President of Home Marketing, leading the marketing and telesales organization for the home hemodialysis business unit. Prior to that, from 2013 to 2015, they were the Senior Director of Customer Experience, responsible for transforming cost centers into a cohesive function focused on customer feedback and needs. From 2011 to 2013, Vivek served as the Director of Sales and Marketing at Medisystems, where they oversaw sales, marketing, distributor relations, and customer service, achieving revenue growth and market share. Vivek also had a role as the Group Marketing Manager at Medisystems, overseeing downstream demand-generation marketing and upstream product management from 2008 to 2010. Before that, they held the position of Chronic Therapies Marketing Manager, where they developed clinical marketing strategies and launched tools for healthcare practitioners. Vivek began their career at NxStage Medical in 2005 as a Product Manager, managing the successful launch of a consumer water purification system.

Prior to their tenure at NxStage Medical, Vivek worked at Inspire! as the Boston Office Head and Case Team Leader from 2004 to 2005. Vivek also worked at The Parthenon Group as a Senior Associate from 2002 to 2005, gaining experience in strategy consulting across industries such as healthcare, education, retail, and finance.

Vivek Menon has a Bachelor of Arts degree with a focus in Economics from Dartmouth College. Vivek also holds a Bachelor of Science degree in Biology, obtained from the same institution. No information is provided regarding the specific years or durations of these educational experiences.

Links

Timeline

  • Co-founder, Strategy & Finance

    January 1, 2024 - present

  • Product, Ops

    June, 2017